UiPath Expands AI Document Processing to Google Cloud, But Core Growth Metrics Unchanged

What happened

UiPath, grappling with slowing ARR growth of 11% and declining net retention to 107% in FY26, is seeking to amplify its AI monetization efforts through new distribution channels. The company announced that its Intelligent Xtraction and Processing (IXP) solution is now available on Google Cloud Marketplace, with Gemini set as the default third-party model for AI-powered automation. This move aims to tap into Google's ecosystem to drive adoption of its AI document processing, which currently contributes nearly $200M in ARR as part of its agentic automation push. However, the partnership does not directly address the critical weaknesses highlighted in the DeepValue report: stagnant expansion rates and incremental ARR that fell to $186.4M in FY26. Investors should view this as a tactical step that supports distribution but lacks immediate financial impact, keeping the focus on upcoming ARR prints and net retention metrics for growth validation.

Implication

The availability on Google Cloud Marketplace could enhance UiPath's visibility and potentially drive incremental sales, especially among Google-centric enterprises seeking AI document automation. However, given the company's history of ARR growth stuck at 11% and net retention declining to 107%, this move alone is unlikely to significantly accelerate expansion or deal sizes without evidence of improved monetization. Investors should closely monitor whether this partnership leads to tangible increases in AI product ARR beyond the disclosed $200M, as scaling this metric is critical for re-acceleration. The announcement reinforces UiPath's strategic focus on AI and cloud alliances, but execution risks persist amid competitive pressures from Microsoft and the need for clearer demand signals. Ultimately, the stock's upside remains contingent on concrete improvements in ARR and NRR, not just distribution partnerships, making the next quarterly results a pivotal test.

Thesis delta

The news does not shift the investment thesis; UiPath remains in a 'WAIT' rating with conviction unchanged, as the partnership supports AI monetization but fails to address the fundamental growth challenges. It underscores the company's efforts to expand its ecosystem, yet the thesis still hinges on ARR re-acceleration and net retention improvement above 108% in upcoming quarters. No upgrade is warranted until financial metrics demonstrate a clear inflection point.